Sponsor

Molecular Partners AG

Wagistrasse 14, 8952

About the sponsor

Molecular Partners AG focuses on blood cancer research in acute myeloid leukemia and myelodysplastic syndrome, with clinical activity centred on relapsed or refractory disease settings.

Acute Myeloid Leukemia
Myelodysplastic Syndrome
Relapsed/Refractory Leukemia

The sponsor’s current clinical work includes evaluation of antileukemic activity in patients with advanced haematologic malignancies.

About Specializations

Molecular Partners AG runs clinical trials in conditions such as Acute myeloid leukaemia, Myelodysplastic syndrome, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study of MP0533 for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Using Sodium Dihydrogen Phosphate Dihydrate, Polysorbate 20, and Sodium Chloride

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:Molecular Partners AG

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →